B101 PHENOTYPING OF ASTHMA IN THE ERA OF BIOMARKERS AND OMICS: High Blood Eosinophil Concentrations And Serum Biomarkers Of Low Il-13 Pathway Activation At Baseline Predict Exacerbation Rate Reduction By Benralizumab For Patients With Moderate To Severe Asthma
Gespeichert in:
Veröffentlicht in: | American journal of respiratory and critical care medicine 2016-01, Vol.193, p.1 |
---|---|
Hauptverfasser: | , , , , , |
Format: | Artikel |
Sprache: | eng |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | |
container_start_page | 1 |
container_title | American journal of respiratory and critical care medicine |
container_volume | 193 |
creator | Newbold, P Wu, Y Shih, V Liang, M Vainshtein, I Ranade, K |
description | |
format | Article |
fullrecord | <record><control><sourceid>proquest</sourceid><recordid>TN_cdi_proquest_journals_1862934721</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>4309761721</sourcerecordid><originalsourceid>FETCH-proquest_journals_18629347213</originalsourceid><addsrcrecordid>eNqNjs1OwzAQhAMqEuXnHVbiHCluUtpyc4pLIsiPkkjAqXITl7gkNthOS3l60sIDcNrdmflWc2oN0dgd295s4gz63Zm4tufNXs6tC603joNGU-QMTwY-chCkAYmT4jUN4wdIFoDzIogwhDEUAQGS4YPoh0mEs0eS5YDje0iicJ7fQcDfavAbKSsgUnMhP2rewFyKkgmjqOFSaMCigpyprgWfy5aqd6Y0JGt4kjsIGxu5kFJT7-gecGn49kgBNuBTzRouGKSKVbw0QL5oydTqN5BRwyBjVVceT38PPhOKNvy7a-kKFlId3vK-h4ZnbmqIZMXUASpkX2fLFAOsTd3SK-tsTRvNrv_mpXWzIMU8sD-U_OyYNsuN7JTorSWa3o5mrjcZIfd_qR_EgXlo</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1862934721</pqid></control><display><type>article</type><title>B101 PHENOTYPING OF ASTHMA IN THE ERA OF BIOMARKERS AND OMICS: High Blood Eosinophil Concentrations And Serum Biomarkers Of Low Il-13 Pathway Activation At Baseline Predict Exacerbation Rate Reduction By Benralizumab For Patients With Moderate To Severe Asthma</title><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Journals@Ovid Ovid Autoload</source><source>American Thoracic Society (ATS) Journals Online</source><source>Alma/SFX Local Collection</source><creator>Newbold, P ; Wu, Y ; Shih, V ; Liang, M ; Vainshtein, I ; Ranade, K</creator><creatorcontrib>Newbold, P ; Wu, Y ; Shih, V ; Liang, M ; Vainshtein, I ; Ranade, K</creatorcontrib><identifier>ISSN: 1073-449X</identifier><identifier>EISSN: 1535-4970</identifier><language>eng</language><publisher>New York: American Thoracic Society</publisher><ispartof>American journal of respiratory and critical care medicine, 2016-01, Vol.193, p.1</ispartof><rights>Copyright American Thoracic Society 2016</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780</link.rule.ids></links><search><creatorcontrib>Newbold, P</creatorcontrib><creatorcontrib>Wu, Y</creatorcontrib><creatorcontrib>Shih, V</creatorcontrib><creatorcontrib>Liang, M</creatorcontrib><creatorcontrib>Vainshtein, I</creatorcontrib><creatorcontrib>Ranade, K</creatorcontrib><title>B101 PHENOTYPING OF ASTHMA IN THE ERA OF BIOMARKERS AND OMICS: High Blood Eosinophil Concentrations And Serum Biomarkers Of Low Il-13 Pathway Activation At Baseline Predict Exacerbation Rate Reduction By Benralizumab For Patients With Moderate To Severe Asthma</title><title>American journal of respiratory and critical care medicine</title><issn>1073-449X</issn><issn>1535-4970</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><recordid>eNqNjs1OwzAQhAMqEuXnHVbiHCluUtpyc4pLIsiPkkjAqXITl7gkNthOS3l60sIDcNrdmflWc2oN0dgd295s4gz63Zm4tufNXs6tC603joNGU-QMTwY-chCkAYmT4jUN4wdIFoDzIogwhDEUAQGS4YPoh0mEs0eS5YDje0iicJ7fQcDfavAbKSsgUnMhP2rewFyKkgmjqOFSaMCigpyprgWfy5aqd6Y0JGt4kjsIGxu5kFJT7-gecGn49kgBNuBTzRouGKSKVbw0QL5oydTqN5BRwyBjVVceT38PPhOKNvy7a-kKFlId3vK-h4ZnbmqIZMXUASpkX2fLFAOsTd3SK-tsTRvNrv_mpXWzIMU8sD-U_OyYNsuN7JTorSWa3o5mrjcZIfd_qR_EgXlo</recordid><startdate>20160101</startdate><enddate>20160101</enddate><creator>Newbold, P</creator><creator>Wu, Y</creator><creator>Shih, V</creator><creator>Liang, M</creator><creator>Vainshtein, I</creator><creator>Ranade, K</creator><general>American Thoracic Society</general><scope>3V.</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AN0</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M1P</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope></search><sort><creationdate>20160101</creationdate><title>B101 PHENOTYPING OF ASTHMA IN THE ERA OF BIOMARKERS AND OMICS: High Blood Eosinophil Concentrations And Serum Biomarkers Of Low Il-13 Pathway Activation At Baseline Predict Exacerbation Rate Reduction By Benralizumab For Patients With Moderate To Severe Asthma</title><author>Newbold, P ; Wu, Y ; Shih, V ; Liang, M ; Vainshtein, I ; Ranade, K</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-proquest_journals_18629347213</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Newbold, P</creatorcontrib><creatorcontrib>Wu, Y</creatorcontrib><creatorcontrib>Shih, V</creatorcontrib><creatorcontrib>Liang, M</creatorcontrib><creatorcontrib>Vainshtein, I</creatorcontrib><creatorcontrib>Ranade, K</creatorcontrib><collection>ProQuest Central (Corporate)</collection><collection>Nursing & Allied Health Database</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>British Nursing Database</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><jtitle>American journal of respiratory and critical care medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Newbold, P</au><au>Wu, Y</au><au>Shih, V</au><au>Liang, M</au><au>Vainshtein, I</au><au>Ranade, K</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>B101 PHENOTYPING OF ASTHMA IN THE ERA OF BIOMARKERS AND OMICS: High Blood Eosinophil Concentrations And Serum Biomarkers Of Low Il-13 Pathway Activation At Baseline Predict Exacerbation Rate Reduction By Benralizumab For Patients With Moderate To Severe Asthma</atitle><jtitle>American journal of respiratory and critical care medicine</jtitle><date>2016-01-01</date><risdate>2016</risdate><volume>193</volume><spage>1</spage><pages>1-</pages><issn>1073-449X</issn><eissn>1535-4970</eissn><cop>New York</cop><pub>American Thoracic Society</pub></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1073-449X |
ispartof | American journal of respiratory and critical care medicine, 2016-01, Vol.193, p.1 |
issn | 1073-449X 1535-4970 |
language | eng |
recordid | cdi_proquest_journals_1862934721 |
source | Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Journals@Ovid Ovid Autoload; American Thoracic Society (ATS) Journals Online; Alma/SFX Local Collection |
title | B101 PHENOTYPING OF ASTHMA IN THE ERA OF BIOMARKERS AND OMICS: High Blood Eosinophil Concentrations And Serum Biomarkers Of Low Il-13 Pathway Activation At Baseline Predict Exacerbation Rate Reduction By Benralizumab For Patients With Moderate To Severe Asthma |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-25T10%3A31%3A02IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=B101%20PHENOTYPING%20OF%20ASTHMA%20IN%20THE%20ERA%20OF%20BIOMARKERS%20AND%20OMICS:%20High%20Blood%20Eosinophil%20Concentrations%20And%20Serum%20Biomarkers%20Of%20Low%20Il-13%20Pathway%20Activation%20At%20Baseline%20Predict%20Exacerbation%20Rate%20Reduction%20By%20Benralizumab%20For%20Patients%20With%20Moderate%20To%20Severe%20Asthma&rft.jtitle=American%20journal%20of%20respiratory%20and%20critical%20care%20medicine&rft.au=Newbold,%20P&rft.date=2016-01-01&rft.volume=193&rft.spage=1&rft.pages=1-&rft.issn=1073-449X&rft.eissn=1535-4970&rft_id=info:doi/&rft_dat=%3Cproquest%3E4309761721%3C/proquest%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1862934721&rft_id=info:pmid/&rfr_iscdi=true |